Imexon

Drugbox
IUPAC_name = 4-imino-1,3-diazabicyclo [3.1.0] hexan-2-one

---

CAS_number = 59643-91-3
ATC_prefix =
ATC_suffix =
PubChem = 68791
DrugBank =
C=4 |H=5 |N=3 |O=1
molecular_weight = 111.102 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.

External links

* [http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=513068 Amplimexon] entry in the public domain NCI Dictionary of Cancer Terms